Characterization of Protein Aggregating Tungstates: Electrospray Mass Spectrometry Analysis of Extracts from Prefilled Syringes and from Tungsten Pins Used in the Manufacture of Syringes

References

1. 1.↵
   1. Nashed-Samuel Y.,
   2. Liu D.,
   3. Fujimori K.,
   4. Perez L.,
   5. Lee H.

   Extractable and leachable implications on biological products in prefilled syringes. Am. Pharm. Rev. 2011, 14 (1), 74.

   OpenUrl
2. 2.↵
   1. Harrison B.,
   2. Rios M.

   Big shot: developments in pre-filled syringes. Pharm. Technol. 2007, 31 (3), 50–56.

   OpenUrl
3. 3.↵
   1. Walsh G.

   Biopharmaceutical benchmarks. Nat. Biotechnol. 2006, 24 (7), 769–776.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Liu W.,
   2. Swift R.,
   3. Torraca G.,
   4. Nashed-Samuel Y.,
   5. Wen Z.,
   6. Vance A.,
   7. Mire-Sluis A.,
   8. Freund E.,
   9. Davis J.,
   10. Narhi L.

   Root cause analysis of tungsten-induced protein aggregation in pre-filled syringes. PDA J. Pharm. Sci. Technol. 2010, 64 (1), 11–19.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Nashed-Samuel Y.,
   2. Torraca G.,
   3. Liu D.,
   4. Fujimori K.,
   5. Zhang Z.,
   6. Wen Z.-Q.,
   7. Lee H.

   Identification of an extraneous black particle in a glass syringe: extractables/leachables case study. PDA J. Pharm. Sci. Technol. 2010, 64 (3), 242–248.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Liu D.,
   2. Nashed-Samuel Y.,
   3. Bondarenko P. V.,
   4. Brems D. N.,
   5. Ren D.

   Interactions between therapeutic proteins and acrylic acid leachable. PDA J. Pharm. Sci. Technol. 2012, 66 (1), 12–19.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Nashed-Samuel Y.

   Extractable and Leachable Implications on Biological Products in Prefilled Syringes. PDA/FDA Joint Regulatory Conference, Washington, DC, September 13–16, 2010.
8. 8.↵
   1. Jiang Y.,
   2. Nashed-Samuel Y.,
   3. Li C.,
   4. Liu W.,
   5. Pollastrini J.,
   6. Mallard D.,
   7. Wen Z.,
   8. Fujimori K.,
   9. Pallitto M.,
   10. Donahue L.,
   11. Chu G.,
   12. Torraca G.,
   13. Vance A.,
   14. Mire-Sluis T.,
   15. Freund E.,
   16. Davis J.,
   17. Narhi L.

   Tungsten-induced protein aggregation: solution behavior. J. Pharm. Sci. 2009, 98 (12), 4695–4710.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Bee J. S.,
   2. Nelson S. A.,
   3. Freund E.,
   4. Carpenter J. F.,
   5. Randolph T. W.

   Precipitation of a monoclonal antibody by soluble tungsten. J. Pharm Sci. 2009, 98 (9), 3290–3301.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Seidl A.,
    2. Hainzl O.,
    3. Richter M.,
    4. Fischer R.,
    5. Böhm S.,
    6. Deutel B.,
    7. Hartinger M.,
    8. Windisch J.,
    9. Casadevall N.,
    10. London G. M.,
    11. Macdougall I.

    Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity. Pharm. Res. 2012, 29 (6), 1454–1467.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Jones L. S.,
    2. Kaufmann A.,
    3. Middaugh C. R.

    Silicone oil induced aggregation of proteins. J. Pharm. Sci. 2005, 94 (4), 918–927.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Thirumangalathu R.,
    2. Krishnan S.,
    3. Ricci M. S.,
    4. Brems D. N.,
    5. Randolph T. W.,
    6. Carpenter J. F.

    Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. J. Pharm. Sci. 2009, 98 (9), 3167–3181.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Redkin A. F.,
    2. Bondarenko G. V.

    Raman spectra of tungsten-bearing solutions. J. Solution Chem. 2010, 39 (10), 1549–1561.

    OpenUrl
14. 14.↵
    1. Chen Y.-G.,
    2. Gong J.,
    3. Qu L.-Y.

    Tungsten-183 nuclear magnetic resonance spectroscopy in the study of polyoxometalates. Coordination Chemistry Reviews 2004, 248 (1), 245–260.

    OpenUrl
15. 15.↵
    1. Smith B. J.,
    2. Patrick V. A.

    Quantitative determination of sodium metatungstate speciation by ¹⁸³W NMR spectroscopy. Australian J. Chem. 2000, 53 (12), 965–970.

    OpenUrl
16. 16.↵
    1. Brevard C.,
    2. Schimpf R.,
    3. Tourne C. M.

    Tungsten-183 NMR: a complete and unequivocal assignment of the tungsten-tungsten connectivities in heteropolytungstates via two-dimensional ¹⁸³W NMR techniques. J. Am. Chem. Soc. 1983, 105 (24), 7059–7063.

    OpenUrlCrossRef
17. 17.↵
    1. Smith B. J.,
    2. Patrick V. A.

    Quantitative determination of sodium dodecatungstosilicate speciation by ¹⁸³W nuclear magnetic resonance spectroscopy. Australian J. Chem. 2002, 55 (4), 281–286.

    OpenUrl
18. 18.↵
    1. Zivkovic O.,
    2. Yan C.,
    3. Wagner M. J.

    Tetragonal alkali metal tungsten bronze and hexagonal tungstate nanorods synthesized by alkalide reduction. J. Mater. Chem. 2009, 19 (33), 6029–6033.

    OpenUrl
19. 19.↵
    1. Reinoso S.,
    2. Giminez-Marques M.,
    3. Galvan-Mascaros J. R.,
    4. Vitoria P.,
    5. Gutierrez-Zorrilla J. M.

    Giant crown-shaped polytungstate formed by self-assembly of Ce^III-stabilized dilacunary Keggin fragments. Angew. Chem. Int. Ed. 2010, 49 (45), 8384–8388.

    OpenUrlPubMed
20. 20.↵
    1. Walanda D. K.,
    2. Burns R. C.,
    3. Lawrance G. A.,
    4. von Nagy-Felsobuki E. I.

    Electrospray mass spectrometry of aqueous solutions of isopolyoxotungstates. J. Cluster Sci. 2000, 11 (1), 5–28.

    OpenUrl
21. 21.↵
    1. Bednar A. J.,
    2. Kirgan R. A.,
    3. Johnson D. R.,
    4. Hayes C. A.,
    5. McGrath C. J.

    Polytungstate analysis by SEC-ICP-MS direct-infusion ESI-MS. Land Decontamination & Reclamation 2009, 17 (1), 129–137.

    OpenUrl
22. 22.↵
    1. Truebenbach C. S.,
    2. Houalla M.,
    3. Hercules D. M.

    Characterization of isopoly metal oxyanions using electrospray time-of-flight mass spectrometry. J. Mass Spectrom. 2000, 35 (9), 1121–1127.

    OpenUrlPubMed
23. 23.↵
    1. Truebenbach C. S.,
    2. Hercules D. M.

    Characterization of isopoly tungstate using time-of-flight electrospray mass spectrometry. Fresenius J. Anal. Chem. 2001, 369 (3-4), 335–341

    OpenUrlPubMed
24. 24.↵
    1. Ma M. T.,
    2. Waters T.,
    3. Beyer K.,
    4. Palamarczuk R.,
    5. Richardt P. J. S.,
    6. O'Hair R. A. J.,
    7. Wedd A. G.

    Gas-phase fragmentation of polyoxotungstate ions. Inorg. Chem. 2009, 48 (2), 598–606.

    OpenUrlPubMed
25. 25.↵
    1. Fujimori K.,
    2. Lee. H.,
    3. Phillips J.,
    4. Nashed-Samuel Y.

    Development of an inductively coupled plasma mass spectrometry method for quantification of extracted tungsten from glass prefilled syringes used as a primary packaging for pharmaceutical and therapeutic protein products. PDA J. Pharm. Sci. Technol. 2013, 67 (6), 670–679.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Christian J. B.,
    2. Whittingham M. S.

    Structural study of ammonium metatungstate. J. Solid State Chem. 2008, 181 (8), 1782–1791.

    OpenUrl
27. 27.↵
    1. Bonchio M.,
    2. Bortolini O.,
    3. Conte V,
    4. Sartorel A.

    Electrospray behavior of lacunary Keggin-type polyoxotungstates [XW₁₁O₃₉]^p− (X=Si, P): mass spectrometric evidence for a concentration-dependent incorporation of an Moⁿ⁺ (M=W^VI, Mo^VI, V^V) unit into the polyoxometalate vacancy. Eur. J. Inorg. Chem. 2003, 4, 699–704.

    OpenUrl
28. 28.↵
    1. Llopis E.,
    2. Ramirez J. A.,
    3. Cervilla A.

    Tungsten (VI)-gluconic acid complexes: polarimetric and 13C-NMR studies in an excess of tungsten (VI). Transition Met. Chem. 1986, 11 (12), 489–494.

    OpenUrl
29. 29.↵
    1. Llopis E.,
    2. Ramirez J. A.,
    3. Cervilla A.

    Tungsten-mannitol and sorbitol complexes: structural characterization by IR and carbon-13 nuclear magnetic resonance spectroscopy, Polyhedron 1986, 5 (12), 2069–2074.

    OpenUrl